World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
65
Citations
13685
World Ranking
2713
National Ranking
1190

Ludwine Messiaen publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Ludwine Messiaen sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 239 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Ludwine Messiaen D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Ludwine Messiaen sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 65 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Ludwine Messiaen is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on neurofibromatosis and related genetic conditions, with a significant body of work exploring diagnostic criteria and molecular mechanisms involved in these disorders.

The scientist has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these, their research emphasizes subfields such as Neurology, Molecular Biology, Rheumatology, Epidemiology, and Pulmonary and Respiratory Medicine.

Key topics covered in their work include:

  • Neurofibromatosis and Schwannoma Cases
  • Chromatin Remodeling and Cancer
  • Meningioma and Schwannoma Management
  • RNA Modifications and Cancer
  • Neuroblastoma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

Frequent collaborators with significant joint publications include:

  • Eric Legius
  • Alicia Gomes
  • D. Gareth Evans
  • P. Wolkenstein
  • David A. Stevenson

Ludwine Messiaen has published multiple articles in prominent venues, with a strong presence in Genetics in Medicine and Human Mutation. Other publication venues include Neurology, Molecular Therapy - Nucleic Acids, and the European Journal of Human Genetics.

Notable papers authored or co-authored by Messiaen include:

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021, Genetics in Medicine)
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022, Genetics in Medicine)
  • "AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides" (2020, Human Mutation)
  • "Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I" (2022, Molecular Therapy - Nucleic Acids)
  • "Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study" (2021, European Journal of Human Genetics)

Best Publications

  • Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

    Ludwine M. Messiaen;Tom Callens;Geert Mortier;Diane Beysen

  • Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

    Hilde Brems;Magdalena Chmara;Magdalena Chmara;Mourad Sahbatou;Ellen Denayer

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation

    M. Upadhyaya;S. M. Huson;M. Davies;N. Thomas

  • Evolution and expression of FOXL2

    J Cocquet;E Pailhoux;F Jaubert;N Servel

  • Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype–phenotype correlation

    Elfride De Baere;Michael J. Dixon;Kent W. Small;Ethylin W. Jabs

  • FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation

    Elfride De Baere;Diane Beysen;Christine Oley;Birgit Lorenz

  • Elucidating distinct roles for NF1 in melanomagenesis.

    Ophélia Maertens;Bryan Johnson;Bryan Johnson;Pablo Hollstein;Pablo Hollstein;Dennie T. Frederick

  • Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas

    Arkadiusz Piotrowski;Arkadiusz Piotrowski;Jing Xie;Ying F Liu;Andrzej B Poplawski

  • Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

    Ophélia Maertens;Hans Prenen;Maria Debiec-Rychter;Agnieszka Wozniak

  • Mutations of VMD2 Splicing Regulators Cause Nanophthalmos and Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC)

    Jill Yardley;Bart P Leroy;Niki Hart-Holden;Bart A Lafaut

  • NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome

    Michael Hölzel;Sidong Huang;Jan Koster;Ingrid Øra

  • Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.

    Ludwine Messiaen;Suxia Yao;Hilde Brems;Tom Callens

  • High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.

    Kitiwan Rojnueangnit;Kitiwan Rojnueangnit;Jing Xie;Alicia Gomes;Angela Sharp

  • Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

    Magdalena Koczkowska;Yunjia Chen;Tom Callens;Alicia Gomes

  • Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

    Scott Randall Plotkin;Jaishri O. Blakeley;D. Gareth Evans;C. Oliver Hanemann

  • Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

    Ophélia Maertens;Sofie De Schepper;Jo Vandesompele;Hilde Brems

  • Quantification of splice variants using real-time PCR

    Ina I. Vandenbroucke;Jo Vandesompele;Anne De Paepe;Ludwine Messiaen

  • Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis

    Lauren T. McGillicuddy;Lauren T. McGillicuddy;Jody A. Fromm;Jody A. Fromm;Pablo E. Hollstein;Pablo E. Hollstein;Sara Kubek

  • Double Inactivation of NF1 in Tibial Pseudarthrosis

    David A. Stevenson;David A. Stevenson;Holly Zhou;Shadi Ashrafi;Ludwine M. Messiaen

Frequent Co-Authors

Anne De Paepe
Anne De Paepe Ghent University Hospital
Kathleen Claes
Kathleen Claes Ghent University Hospital
Eric Legius
Eric Legius KU Leuven
Bruce R. Korf
Bruce R. Korf University of Alabama at Birmingham
Meena Upadhyaya
Meena Upadhyaya Cardiff University
Hildegard Kehrer-Sawatzki
Hildegard Kehrer-Sawatzki University of Ulm
Franki Speleman
Franki Speleman Ghent University
Geert Mortier
Geert Mortier University of Antwerp
Elfride De Baere
Elfride De Baere Ghent University
David Neil Cooper
David Neil Cooper Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens doors to a variety of online degrees and career options in healthcare and life sciences. If you’re interested in patient care, consider accredited nursing schools without teas test requirements, which streamline the application process and get you started sooner.

For those seeking fast entry into the workforce, a 6 months lpn program can provide practical nursing skills in less than a year. If you have ambitions for leadership or hospital administration, you might explore mha online programs—these master’s programs are flexible and affordable, ideal for busy professionals.

For those interested in advancing research or academic careers, there are also options for an online nursing doctorate, which can prepare you for top roles in teaching or clinical research. Each pathway offers unique opportunities for specialization and career growth alongside genetics.

Best Scientists Citing Ludwine Messiaen

Trending Scientists

Recently Published Articles